A Review on Different Analytical Techniques for Determination of DNP Drugs and their Metabolites in Pharmaceutical Formulations

被引:1
作者
Bag, Puja [1 ]
Kumar, Bhupinder [1 ,2 ]
机构
[1] ISF Coll Pharm, Dept Pharmaceut Anal, GT Rd, Moga 142001, Punjab, India
[2] ISF Coll Pharm, Dept Pharmaceut Chem, GT Rd, Moga 142001, Punjab, India
关键词
Diabetic neuropathy drugs; liquid chromatography-mass spectrometry; high performance liquid chromatography; ultraviolet-visible spectrophotometer method; analytical method development; pharmaceutical analysis; DIABETIC PERIPHERAL NEUROPATHY; ALPHA-LIPOIC ACID; LC-MS/MS METHOD; HUMAN PLASMA; RAT PLASMA; PHARMACOLOGICAL-TREATMENT; PAINFUL NEUROPATHY; GLYCEMIC CONTROL; HPLC METHOD; PREGABALIN;
D O I
10.2174/1573412916999200825112708
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Neuropathy is the most common perplexity of diabetes type 1 and 2. About 50% of diabetic patients develop diabetic neuropathic pain (DNP). At the beginning of diabetic neuropathy, there is a loss of sense, especially in the lower limb, accompanied by pain, and difficulty in movement. Glucose regulation effectively prevents the development of diabetic neuropathy in type 1 diabetic patients, but the consequences in type 2 diabetic patients are more drastic. Introduction: No single treatment exists to prevent or renovate the pain caused by diabetic neuropathy. The drugs used for the treatment of DNP come in various formulations and with different storage conditions. To date, a number of analytical methodologies have been reported for the analysis of DNP drugs. Few reports are published describing analytical methods of single DNP drugs. Methods: The main objective of this review is to compile the different analytical methods developed at UV-Vis (Ultraviolet-visible) spectrophotometer, HPLC (High Performance Liquid Chromatography), and LC-MS (Liquid Chromatography-Mass spectrometry) to identify and quantify the drug content in various formulations, which are used to treat or prevent the diabetic neuropathic pain mainly focusing on gamma-aminobutyric acid analogues, anti-depressants, Serotonin Noradrenaline Reuptake Inhibitors (SNRIs), aldose reductase inhibitors, opioids, and dietary supplements. Results and Discussion: We have compiled UV-Vis, HPLC, and Liquid Chromatography-Mass spectrometry analytical methods developed to study the pharmacokinetic profile, quantify drug content, and their metabolites in plasma as well as pharmaceutical formulations. Conclusion: The authors believe that the mentioned studies in the report will help audible readers to select a suitable method for analysis of these drugs and also help researchers to develop a more convenient, fast, and sensitive method for these.
引用
收藏
页码:1132 / 1155
页数:24
相关论文
共 102 条
  • [31] Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity
    Dyck, Peter J.
    Albers, James W.
    Andersen, Henning
    Arezzo, Joseph C.
    Biessels, Geert-Jan
    Bril, Vera
    Feldman, Eva L.
    Litchy, William J.
    O'Brien, Peter C.
    Russell, James W.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (07) : 620 - 628
  • [32] Validated stability-indicating methods for determination of cilostazol in the presence of its degradation products according to the ICH guidelines
    Fayed, Ahmad S.
    Shehata, Mostafa A.
    Ashour, Ahmed
    Hassan, Nagiba Y.
    Weshahy, Soheir A.
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2007, 45 (03) : 407 - 416
  • [33] The evidence for pharmacological treatment of neuropathic pain
    Finnerup, Nanna Brix
    Sindrup, Soren Hein
    Jensen, Troels Staehelin
    [J]. PAIN, 2010, 150 (03) : 573 - 581
  • [34] Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy - Findings from seven randomized, controlled trials across a range of doses
    Freeman, Roy
    Durso-Decruz, Edith
    Emir, Birol
    [J]. DIABETES CARE, 2008, 31 (07) : 1448 - 1454
  • [35] A rapid and sensitive liquid chromatography tandem mass spectrometric assay for duloxetine in human plasma: Its pharmacokinetic application
    Gajula, Ramakrishna
    Maddela, Rambabu
    Ravi, Vasu Babu
    Inamadugu, Jaswanth Kumar
    Pilli, Nageswara Rao
    [J]. JOURNAL OF PHARMACEUTICAL ANALYSIS, 2013, 3 (01) : 36 - 44
  • [36] Identification of Related Substances in Citicoline Sodium Injection by HPLC-DAD and HPLC-MS/MS
    Gao, Jin
    Zhao, Ming
    Fu, Xiaoying
    Zhang, Jiong
    Ji, Yang
    Jiang, Xiongping
    Fu, Xiaofei
    Zhao, Chunjie
    [J]. ASIAN JOURNAL OF CHEMISTRY, 2013, 25 (14) : 7697 - 7704
  • [37] Garikapati DR., 2012, International Current Pharmaceutical Journal, V1, P98, DOI DOI 10.3329/ICPJ.V1I5.10281
  • [38] Goday S., 2018, ASIAN J PHARM CLIN R, V11, P319, DOI [10.22159/ajpcr.2018.v11i5.22256, DOI 10.22159/AJPCR.2018.V11I5.22256]
  • [39] Gor J.H., 2013, INT J DRUG DEV RES, V5, P356
  • [40] THE CLINICAL SPECTRUM OF INFLAMMATORY-ANGIOPATHIC NEUROPATHY
    HARATI, Y
    NIAKAN, E
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (11) : 1313 - 1316